Evaluation of Correlations Between Volatile Organic Compounds and Venous Blood Glucose in Subjects With Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

March 30, 2025

Study Completion Date

October 30, 2025

Conditions
Type 2 Diabetes
Interventions
DEVICE

MIB Breath Analyzer

"Going through visit-specific blood glucose excursions by the administration of glucose and insulin (clamp), monitoring physiological processes, and measuring reference blood glucose values and VOC measurements in the breath using a GC-IMS and the MIBs (investigational devices).~Going through visit-specific blood glucose excursions by consuming a standardized meal, monitoring physiological processes, and measuring reference blood glucose values and VOC measurements in the breath using a GC-IMS and the MIBs (investigational devices)~Imitating the glucose excursion from the meal excursion by infusing glucose and insulin (clamp), monitoring physiological processes, and measuring reference blood glucose values and VOC measurements in the breath using a GC-IMS and the MIBs (investigational devices)."

Trial Locations (1)

3010

RECRUITING

Inselspital Bern, Bern

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

BOYDSENSE

INDUSTRY

lead

DCB Research AG

OTHER